Addus HomeCare (ADUS)
(Delayed Data from NSDQ)
$133.58 USD
+1.19 (0.90%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $133.46 -0.12 (-0.09%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$133.58 USD
+1.19 (0.90%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $133.46 -0.12 (-0.09%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Zacks News
Addus HomeCare (ADUS) Q3 Earnings Preview: What to Look Out For
by Zacks Equity Research
Addus HomeCare (ADUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for October 22nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for October 5th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for October 1st
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for September 24th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for September 20th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for September 18th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for September 11th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for September 7th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for September 6th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for September 5th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for August 27th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for August 22nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for August 20th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Addus HomeCare (ADUS) Q2 Earnings Lag Estimates
by Zacks Equity Research
Addus HomeCare (ADUS) delivered earnings and revenue surprises of -1.96% and 2.68%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for June 29th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
EVHC vs. ADUS: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
EVHC vs. ADUS: Which Stock Is the Better Value Option?
Is a Summer Swoon On the Way?
by John Blank
June is historically a flat month for stocks. Any catalysts this time?
ADUS vs. USPH: Which Stock Is the Better Value Option?
by Zacks Equity Research
ADUS vs. USPH: Which Stock Is the Better Value Option?
No Spending Lift from the Consumer? Zacks June Market Strategy
by John Blank
Real Personal Consumption expenditures has been strikingly weak in this recovery. A peak of +3.9% in Real PCE happened in Q1-2015. This growth rate has been sliding down ever since.
What Falling Estimates & Price Mean for Quorum Health (QHC)
by Zacks Equity Research
Quorum Health (QHC) is one stock you should avoid as it has seen a significant price decline and is also seeing negative earnings estimate revisions.
4 Value Stocks for Growth Investors to Enrich Portfolio
by Trina Mukherjee
On the back of an improving economy, we have zeroed in on four value stocks for growth investors, likely to enrich their portfolio.
The Zacks Analyst Blog Highlights: UnitedHealth, Envision, Addus and Adverum
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, Envision, Addus and Adverum
3 Healthcare Stocks Set to Beat Q1 Earnings Estimates
by Zacks Equity Research
Elevated flu activity, aging population, high expenses, and a low tax rate would influence healthcare stocks' earnings in Q1.
Envision Healthcare (EVHC) to Report Q1 Earnings: What's Up?
by Zacks Equity Research
Envision Healthcare's (EVHC) Q1 earnings should see an upside from higher revenues at both its segments.